Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT)

• Published in: BMC neurology Vol. 18; no. 1; pp. 133 - 13
• Main Authors: Li, Jianlong, Li, Qingbin, Lin, Lin, Wang, Rui, Chen, Lingchao, Du, Wenzhong, Jiang, Chuanlu, Li, Ruiyan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 31.08.2018; BioMed Central; BMC
• Subjects: Apoptosis; Brain cancer; Cadherins; Cancer therapies; Cell cycle; Chemoresistance; EMT; Epithelial cells; Genetic aspects; Glioma; Glioma cells; Gliomas; Immunofluorescence; Immunohistochemistry; Liver cancer; Medical prognosis; Mesenchyme; Metastases; Metastasis; MicroRNA; MicroRNAs; miR-139-5p; miRNA; N-Cadherin; Notch1; Notch1 protein; Oncogenes; Prognosis; Reversion; Risk factors; siRNA; Snail protein; Transcription; Tumors; Wound healing; Glioma; Notch1; EMT; miR-139-5p
• ISSN: 1471-2377; 1471-2377
• DOI: 10.1186/s12883-018-1139-8

Glioma metastasis, invasion, epithelial-mesenchymal transition (EMT) and chemoresistance indicate poor prognosis. Accumulating evidence reveals that Notch1 is an important factor in tumour progression. However, the role of Notch1 in glioma EMT and associated microRNAs (miRNAs) with the Notch pathway remain controversial. Utilizing cBioPortal database to examine the gene signature of NOTCH1 (encoding Notch1), CDH2 (encoding N-cadherin) and SNAI1 (encoding Snail-1) in disease-free survival (DFS) and overall survival (OS). We analyzed the Notch1 expression from Oncomine. We used Western blot (WB), immunohistochemistry (IHC) and immunofluorescence to determine protein levels. Transcription was evaluated by quantitative real-time (qRT)-PCR. siRNA and lentivirus were used to knock down Notch1 and overexpress miR-139-5p, respectively. The migration and invasion of glioma cells were assessed by wound healing and transwell assays. Luciferase reporter assays were utilized to verify the relationship between Notch1 and miR-139-5p. A U87-implanted intracranial model was used to study the effect of miR-139-5p on tumour growth and Notch1 suppression efficacy or EMT reversion. It revealed the association of NOTCH1, CDH2, SNAI1 genomic alterations with decreases in DFS and OS. Notch1 was upregulated in classical and proneural subtypes of GBM, and associated with tumour grade. Notch1 inhibition suppressed the biological behaviours of metastasis, invasion and EMT. Notch1 was identified as a novel direct target of miR-139-5p. MiR-139-5p overexpression partially phenocopied Notch1 siRNA, whereas the forced expression of Notch1 reversed the effects of miR-139-5p on the invasion of glioma. Moreover, intracranial tumourigenicity and EMT behaviours were reduced by the introduction of miR-139-5p and partially mediated by the decreased Notch1 expression. miR-139-5p was identified as a tumour suppressor by negatively targeting Notch1, and this work suggests a possible molecular mechanism of the miR-139/Notch1/EMT axis for glioma treatment.